Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Value of Anti-Pax-5 Immunostaining in Routinely Fixed and Paraffin-Embedded Sections

1 Oct 2002

Abstract excerpt

Whereas L26 (anti-CD20) is well established as a B-cell marker of high specificity for use in paraffin-embedded tissues and JCB117 (anti-CD79a) is increasingly used, a comparable additional pan-B-cell antibody has hitherto not yet been identified. Here we have studied the use of a novel anti-pan-B-cell marker Pax-5 for use in diagnostic pathology. Pax-5 encodes for BSAP (Pax-5), a B-cell-specific transcription...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Cell Function and Interaction
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12360049
DOI: 10.1097/00000478-200210000-00011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Value of Anti-Pax-5 Immunostaining in Routinely Fixed and Paraffin-Embedded SectionsPMID 12360049Read ↗

PAX5 as a diagnostic tool in unconventional acute leukemia: Establishing immunohistochemical evidence of B-cell lineageSemantic proximity Read ↗

Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.Semantic proximity Read ↗

The <i>Pax-5</i> Gene: A Pluripotent Regulator of B-cell Differentiation and Cancer DiseaseSemantic proximity Read ↗

Transcription Factor B-Cell–Specific Activator Protein (BSAP) Is Differentially Expressed in B Cells and in Subsets of B-Cell LymphomasSemantic proximity Read ↗

Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.Semantic proximity Read ↗

Immunophenotyping of hematologic neoplasms in paraffin-embedded tissue sections.Semantic proximity Read ↗

The regulation of the B‐cell gene expression programme by Pax5Semantic proximity Read ↗

Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis.Semantic proximity Read ↗

Perspectives on fetal derived CD5 + B1 B cellsSemantic proximity Read ↗

Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.Semantic proximity Read ↗

Comparative genome‐wide profiling of post‐transplant lymphoproliferative disorders and diffuse large B‐cell lymphomasSemantic proximity Read ↗

PAX5/TEL Acts as a Transcriptional Repressor Causing Down-modulation of CD19, Enhances Migration to CXCL12, and Confers Survival Advantage in pre-BI CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.